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ABSTRACT: There is a controversy about the extent to
which the primary and secondary dielectric relaxations
inﬂuence the crystallization of amorphous organic compounds
below the glass transition temperature. Recent studies also
point to the importance of fast molecular dynamics on
picosecond-to-nanosecond time scales with respect to the glass
stability. In the present study we provide terahertz spectros-
copy evidence on the crystallization of amorphous naproxen
well below its glass transition temperature and conﬁrm the
direct role of Johari−Goldstein (JG) secondary relaxation as a
facilitator of the crystallization. We determine the onset temperature Tβ above which the JG relaxation contributes to the fast
molecular dynamics and analytically quantify the level of this contribution. We then show there is a strong correlation between
the increase in the fast molecular dynamics and onset of crystallization in several chosen amorphous drugs. We believe that this
technique has immediate applications to quantify the stability of amorphous drug materials.
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■ INTRODUCTION
Amorphous solids are high energy materials compared to their
crystalline counterparts and characterized by the absence of a
long-range three-dimensional molecular order.1 The molecules
within an amorphous material are thought to reﬂect the
disorder in structure found in the liquid state but with
rheological properties of a solid.2 The most pronounced feature
of an amorphous material is its glass transition, where an abrupt
change in molecular mobility occurs.3 Below the glass transition
temperature (Tg), the molecules are in the glassy state and
kinetically frozen in, characterized by low molecular mobility.
Because of the high internal energy, amorphous solids generally
have a higher kinetic solubility and dissolution rate.1,4 This can
be exploited for applications such as in the pharmaceutical ﬁeld
to increase bioavailability of poorly soluble drugs when
administered orally in the form of tablets or capsules. However,
from a thermodynamic point of view, these systems are
unstable and experience an intrinsic drive to convert to a lower
energy and stable crystalline form over time. In order to be able
to exploit the properties of the amorphous form practically one
needs to ensure physical stability at least for the duration of the
shelf life of e.g. pharmaceutical formulations.
The process of recrystallization is a complex phenomenon of
crystal nuclei formation and crystal growth. The recrystalliza-
tion kinetics, and thus the physical stability of amorphous
systems, has been discussed widely in the literature and was
related to thermodynamic,5,6 kinetic,7,8 and molecular driving
forces.9−11 In order to minimize the risk of recrystallization,
amorphous systems should be stored at temperatures far below
Tg and at low humidity to reduce molecular mobility.
1,4 Often,
it is assumed the glass is completely stable below temperatures
of Tg − 20 K or Tg − 50 K, where the primary molecular
mobility present in liquids no longer exists on the relevant time
scales.
It is however becoming clearer that even at low temperatures
there is molecular mobility that gives rise to an instability of the
amorphous system, originating from the Johari−Goldstein (JG)
secondary relaxation.12−15 While this is usually best observed by
dielectric spectroscopy, experimental evidence from neutron
and light scattering shows that nanosecond-to-picosecond
molecular dynamics measured by these techniques are also
extremely sensitive to any changes in the molecular dynamics
during the glass transition16,17 and reﬂect on the overall stability
of glassy systems.18
A recent study showed that terahertz spectroscopy is very
sensitive to the changes in the picosecond molecular dynamics
both above and below Tg.
19 It was shown that the decrease in
global mobility at Tg, represented by the primary dielectric
relaxation, has a clearly measurable eﬀect on the temperature
behavior of terahertz absorption. The study also found that in
the case of polyalcohols, at Tβ ≈ 0.67 Tg, there is another
Received: April 29, 2015
Revised: May 30, 2015
Accepted: June 19, 2015
Published: June 19, 2015
Article
pubs.acs.org/molecularpharmaceutics
© 2015 American Chemical Society 3062 DOI: 10.1021/acs.molpharmaceut.5b00330
Mol. Pharmaceutics 2015, 12, 3062−3068
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
signiﬁcant change in the picosecond molecular mobility that is
strongly linked to the diminishing JG secondary relaxation.
In this work we show that the onset of molecular mobility at
Tβ directly facilitates the crystallization of an amorphous system
deeply below its Tg and that there is a strong correlation
between this type of molecular mobility and the stability of
amorphous molecular systems. Hence, we outline the
possibility to use terahertz spectroscopy for stability testing of
amorphous systems, such as amorphous drugs, in order to
prevent their crystallization over the shelf life of a ﬁnal product.
■ MATERIALS AND METHODS
Materials. Paracetamol, indomethacin, and ﬂufenamic acid
were obtained from Sigma-Aldrich (St. Louis, MA, USA).
Naproxen was purchased from Divis Laboratories Ltd.
(Florham Park, NJ, USA). Simvastatin was obtained from
Dalian Melian Biotech Co. (Dalian, China). All substances were
of reagent grade (see Figure 1).
Preparation of Amorphous Samples. The pure
amorphous drugs were prepared freshly prior to the terahertz
measurements by melting the crystalline powder at approx-
imately 450 K followed by fast cooling of the melt to room
temperature and subsequent slow cooling to 80 K. Because of
its fast recrystallization at room temperature, crystalline
naproxen was molten in situ within the sample holder and
directly immersed into liquid nitrogen before the measure-
ments.
Temperature Controlled Terahertz Spectroscopy
(THz-TDS). The terahertz absorption spectra were obtained
using THz-TDS as described previously.20 Spectra were
acquired in the frequency range of 0.2−2.0 THz and over a
temperature range of 80−320 K. The samples were loaded
between two z-cut quartz windows of 13 mm diameter
separated by a PTFE spacer of 190 μm thickness. The pure
naproxen sample was prepared between two PTFE windows to
avoid shattering the windows during quench-cooling. The
spectra were measured during heating of the sample from 80 K
with 10 K steps. The estimated accuracy in temperature control
is 1 K. Terahertz frequency data were extracted from the time-
domain data in a fashion described elsewhere.21
X-ray Powder Diﬀraction (XRPD). XRPD was performed
using a PANalytical X-Pert PRO X-ray Diﬀractometer (Almelo,
The Netherlands) with Cu Kα radiation (λ = 1.54187 Å). The
acceleration voltage and current were 40 kV and 30 mA.
Samples were analyzed in reﬂection mode between 5° and 35°
2θ applying a scan speed of 0.1285° 2θ/s and a step size of
0.0084° 2θ.
Diﬀerential Scanning Calorimetry (DSC). Glass tran-
sition temperature (Tg, midpoint) determination was per-
formed using a TA Discovery DSC (TA-Instruments-Waters
LLC, New Castle, DE, USA) attached with a TA Instruments
Quench Cooling Accessory (Q Series). Approximately 3−5 mg
of amorphous sample were crimped into a Tzero aluminum pan
with lid. Measurements at a scanning rate of 10 K/min were
carried out from 150 to 10 K above the melting point of the
respective compound.
Physical Stability Studies. The stability of amorphous
drugs represents the onset of crystallization in amorphous
samples. The onset of crystallization was determined as the
time when the ﬁrst crystalline reﬂections appeared in the XRPD
diﬀractograms. The stability was determined for samples stored
under dry storage conditions (phosphorus pentoxide) in
desiccators at 277 and 298 K. The samples were exposed to
room conditions during the measurement. The sensitivity of
XRPD is approximately 1% of crystalline amount in amorphous
material.22
The time resolution of the stability check procedure was as
follows. The unstable samples naproxen, paracetamol, and
ﬂufenamic acid recrystallized within 1 day; therefore, they were
recorded directly after preparation and the day after. Note that
paracetamol and ﬂufenamic acid recrystallized very fast at room
temperature, so the observation of recrystallization was done
visually by checking the samples in the optically transparent
desiccator, since removing samples from the desiccator for
XRPD analysis would initiate recrystallization. The visual check
is straightforward as the amorphous form is a transparent glass,
but when it starts recrystallizing it becomes white and cloudy.
The other samples were tested roughly every week, with
increasing time intervals after week 4.
■ RESULTS
Crystallization of Amorphous Naproxen below Tg.
Terahertz spectroscopy is a very sensitive technique to monitor
crystal formation in the (supercooled) liquid state above
Tg.
23−25 This analysis can be extended to samples that
crystallize below Tg. An excellent example of such a material
is naproxen, which has an extraordinarily strong tendency to
crystallize even at temperatures below its Tg = 279 K.
Amorphous naproxen is stable for only about 1 min at a
temperature of 273 K (Tg −5 K), and very rapid cooling rates
are necessary to obtain samples of fully amorphous naproxen.26
The terahertz spectra of naproxen are shown in Figure 2. In
general, fully amorphous systems exhibit a power-law frequency
dependence of terahertz absorption due to the coupling of the
terahertz radiation to the vibrational density of states (VDOS),
and no distinct narrow spectral peaks, as commonly observed in
the crystalline state, are expected at frequencies below 3 THz
for organic materials.19,27−29 Upon heating an amorphous
sample the terahertz absorption is expected to increase as a
result of an increasing molecular mobility.19
The spectra of naproxen at 100 K reveal a broad peak
centered at around 1.25 THz, which becomes sharper upon
further heating of the sample and its subsequent crystallization.
This means that a small amount of crystalline seeds was already
present in the sample following the preparation by quench-
cooling. A pure amorphous sample could not however be
obtained even after multiple attempts of fast quench-cooling by
submerging the sample cell directly into liquid nitrogen.
Figure 1. Molecular structures of samples used in the study.
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The spectra in Figure 2 clearly reveal that the naproxen
sample crystallized continuously upon heating and was fully
crystalline at around 270 K, close to its Tg. A visual check
conﬁrmed that the sample of naproxen was fully crystalline at
the end of the experiment. The presence of crystalline seeds in
the sample most likely acted as nucleation centers for the
subsequent crystallization. The absorption changes with
temperature in a linear fashion (Figure 2b). The linear analysis
in Table 1 shows that the decrease in absorption becomes
about 4 times larger when the temperature exceeds 190 K, ≈
0.67, Tg. It has been previously shown that in the case of
amorphous organic systems there is a temperature Tβ < Tg
above which the molecular mobility becomes enhanced despite
the system being still deeply in its glassy state. This onset of
mobility is linked to the JG relaxation having an inﬂuence on
the fast caged dynamics of molecules, as explained further in
the section ‘Origin of Tβ’. For example, in the case of
amorphous polyalcohols it was shown that Tβ ≈ 0.67, Tg.
19
This temperature matches extremely well with the observed
enhancement of naproxen crystallization in Figure 2 with our
previous observation of Tβ, i.e. the onset of the fast molecular
mobility due to the JG relaxation.19 The results on naproxen
therefore directly demonstrate the connection between Tβ, fast
molecular dynamics and ability of amorphous material to
crystallize.
Correlation of Terahertz Spectra with the Stability of
Amorphous Drugs. Similarly to the previous study of
polyalcohols,19 the amorphous drugs also exhibit the same
behavior of Tβ ≈ 0.67 Tg as can be seen from the spectra of
amorphous paracetamol and indomethacin in Figure 3. While
the absolute level of terahertz absorption of polyalcohols in the
previous study was very similar, this is no longer true for the
drugs in this study. Therefore, in order to be able to compare
the increase in the terahertz absorption due to the onset of
molecular mobility at temperatures above Tβ it is necessary to
rescale the temperature by Tg and also to ﬁnd a comparable
metric to normalize the absorption coeﬃcient. We rescale the
absorption coeﬃcient by the average of its values below 0.67 Tg
at a frequency of 1 THz. This particular frequency was chosen
as our terahertz system provides the highest sensitivity around
this frequency.
The rescaled absorption at 1 THz for amorphous para-
cetamol, indomethacin, ﬂufenamic acid, and simvastatin are
shown in Figure 4. Generally, these results exhibit three
diﬀerent temperature regimes, similarly to what was previously
observed in case of polyols:19 (i) very weakly temperature-
dependent absorption at the lowest temperatures, (ii)
intermediate temperature dependent absorption at higher
temperatures yet still below Tg, and (iii) relatively strongly
dependent terahertz absorption above Tg. Data in the regions
(i), (ii), and (iii) of these regions were ﬁtted using a linear
function α/α0(T/Tg) = A + BT/Tg, separately for all three
Figure 2. (a) Terahertz absorption spectra of quench-cooled naproxen
in the thermal range 100−310 K. (b) Terahertz absorption coeﬃcient
at 1.2 THz, 1.5 THz, and 1.8 THz as a function of rescaled
temperature T/Tg. The solid lines represent a linear ﬁt. [Given the
diﬃculty in the sample preparation the absolute values of the
absorption coeﬃcient are likely to be aﬀected to some extent by
scattering of terahertz radiation on the crystalline seeds and possibly
lack of perfect plane-parallelism of the sample. The impact of these
discrepancies on the relative change of absorption with temperature is
however insigniﬁcant.]
Table 1. Linear Coeﬃcient c of Change in Absorption with
Temperature Determined from the Linear Fit α(T/Tg) = a +
cT/Tg of Naproxen in the Temperature Region below 0.67Tg
(c1) and between 0.67−1.0Tg (c2) at 1.2 THz, 1.5 THz, and
1.8 THza
frequency
(THz)
c1
(cm−1)
c2
(cm−1) c2/c1 Tβ/Tg Tβ (K)
1.2 −41 −179 4.4 0.69 ± 0.08 192 ± 22
1.5 −79 −281 3.6 0.70 ± 0.08 196 ± 21
1.8 −138 −432 3.1 0.67 ± 0.06 187 ± 17
aTβ designates the crossover temperature between the two thermal
regions.
Figure 3. (a) Terahertz absorption spectra of amorphous paracetamol
and indomethacin in the thermal range 100−320 K. (b) Terahertz
absorption coeﬃcient at 1.0 THz as a function of rescaled temperature
T/Tg. The solid lines represent a linear ﬁt.
Figure 4. Terahertz absorption spectra of amorphous paracetamol,
ﬂufenamic acid, indomethacin, and simvastatin at 1.0 THz. The
absorption coeﬃcient is rescaled by the low-temperature average α0;
the temperature is rescaled by Tg. The solid lines represent a linear ﬁt.
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thermal regions, except for simvastatin where such an attempt
was hampered by barely distinguishable regions (i) and (ii).
Simvastatin showed a signiﬁcant increase in the terahertz
absorption from 285 K onward despite the fact that its Tg = 303
K as determined by DSC. It is not clear what the molecular
origin of this discrepancy is between the thermal behavior and
the molecular relaxations. We believe that this is likely owing to
the intramolecular ﬂexibility of the simvastatin molecule and its
ability to form partly disordered conformations via rotations of
the ester tail with low energy barriers between these.30 For the
linear ﬁtting we therefore decided to use Tg = 285 K, as it
reﬂects on the actual molecular dynamics and provides an
upper estimate of the absorption thermal coeﬃcient B2. The
temperature Tβ corresponds to the transition point between
regions (i) and (ii) and has been determined by extrapolating
the linear ﬁts of data in the regions (i) and (ii), respectively.
The outcomes of the linear ﬁtting are shown in Table 2,
where we show the crossover temperature Tβ between regions
(i) and (ii) as determined from adjacent linear ﬁts, together
with the linear thermal absorption coeﬃcient B2 obtained for
temperature region (ii) as well as the stability data. The stability
of the amorphous drugs was determined as an onset of the ﬁrst
detectable traces of the crystalline phase in the XRPD
diﬀractograms. One may immediately notice a correlation
between the stability results and absorption thermal coeﬃcient
B2.
■ DISCUSSION
Origin of Tβ. While the change in the terahertz absorption
at Tg and Tβ is clearly linked to the primary and JG dielectric
relaxations respectively as shown previously,19 it is important to
further clarify the exact mechanism. Despite their broad
frequency nature, the primary and JG relaxation processes are
generally too slow to extend to the terahertz frequency range at
temperatures of Tg and below. However, their inﬂuence extends
to the terahertz frequencies through the caged dynamics
losses.17,31 The caged dynamics result in nearly constant type of
dielectric losses that cover the range between the fastest
secondary relaxation and the lowest structural vibrations from
the VDOS in amorphous materials. This part of the dynamics
contains information on the manner in which a disordered
system experiences the transition from vibrational to relaxa-
tional dynamics.32
It was shown previously that while the caged dynamics
themselves are observed in the gigahertz frequencies region, the
glass transition leads to a change in the caged dynamics, likely
through the direct physical eﬀect on the cages themselves.16
The change of terahertz absorption with temperature at Tg
(Figure 4) can therefore be explained as an eﬀect of primary
relaxation on the caged dynamics. Similar arguments can be
used to explain the changes at Tβ in terms of an eﬀect of the JG
relaxation on the caged dynamics. This argumentation is further
supported by the fact that there is a direct link between the JG
secondary relaxation time and the amplitude of the losses
induced by the caged dynamics.33 There is good evidence of
JG-β relaxation present in paracetamol below Tg based on
previous dielectric studies.34 In the case of indomethacin the
JG-β relaxation was also clearly observed, although only at
elevated pressure.35 Both results thus further support the
relevance of the JG relaxation for the stability of amorphous
solids below Tg. Unfortunately, to our knowledge there are no
reported data on secondary dielectric relaxations for ﬂufenamic
acid and simvastatin.
It should also be kept in mind that due to its vibrational
(librational) origin, the broad VDOS peak is expected to shift
slightly to higher frequencies upon cooling a glass, resulting
eﬀectively in loss of terahertz absorption at frequencies below
the maximum of the VDOS. This shift originates from the
intermolecular hydrogen bonding getting stronger upon
cooling. Given that we cannot resolve the full VDOS peak
with our current experimental technique, it is not possible to
perform an accurate analysis of this eﬀect. It is however
apparent that lowering the relaxational contribution to the
terahertz absorption and shifting the vibrational contribution to
higher frequencies will constructively result in lower terahertz
absorption, enhancing the sensitivity of THz-TDS toward the
overall eﬀect. The task of diﬀerentiating between these eﬀects
remains to be addressed in future studies as it requires a
terahertz spectroscopy system that allows one to measure
dielectric losses accurately up to at least 5 THz in order to
cover most of the VDOS peak.
Role of Fragility on Glass Stability. There is an ongoing
dispute on the role of fragility on glass stability.15,36 Reported
values for fragility of paracetamol from various studies are m =
86.737 and m = 67.7,36 and m = 6438 and m = 60.236 for
indomethacin. However, the fragility of simvastatin is m = 73,36
and the relationship between the observed increase in terahertz
absorption above Tβ and fragility, as well as stability and
fragility, does not hold. A further argument against the link of
fragility to sub-Tg terahertz losses originates from the fact that
glycerol has a fragility of around m = 57, close to indomethacin,
yet no signiﬁcant changes in the terahertz losses were observed
below its Tg.
19
The lack of relation between the fragility and glass stability
has been already highlighted in previous work.36 The present
study oﬀers further insight into this topic, as it conﬁrms that it
is the JG relaxation that plays a dominant role in the glass
stability below Tg. In contrast it is important to highlight that
the fragility is an expression of the diminishing molecular
kinetics that are related to the primary relaxation, which
however plays no role around Tβ.
Role of Intermolecular Bonding on Glass Stability.
Commonly the primary and secondary relaxations are
considered to be the source of the molecular mobility while
in reality they are only a consequence of it. The molecular
mobility, that allows for relaxation of glass and the occurrence
of crystallization, originates from the chemical bonding between
the molecules. It has been shown, especially in multicomponent
Table 2. Stability tstable of Studied Amorphous Drugs
Expressed As Time before Any Crystallization Was Detected
at 277 and 298 K, Glass-Transition Temperature Tg
Determined by DSC, Together with the Linear-Fit Analysis
of Absorption Losses, α/α0(T/Tg) = A + BT/Tg, as Shown in
Figure 4a
sample
tstable at
277 K
(day)
tstable at
298 K
(day)
Tg
(K)
Tβ
(K) Tβ/Tg B2
ﬂufenamic acid 4 1 285 160 0.55 0.42 ± 0.15
paracetamol 45 1 297 194 0.65 0.45 ± 0.05
indomethacin 136 7 318 243 0.76 0.34 ± 0.09
simvastatin >84 >220 303 0.18 ± 0.03
aB2 is the linear coeﬃcient obtained from ﬁts in the temperature
region between Tβ and Tg.
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systems, that molecular interactions (e.g., hydrogen bonding)
play a crucial role in the stabilization of the amorphous
form.39,40 In the coamorphous systems naproxen-cimetidine
and indomethacin-naproxen for example, it was found that the
low-range molecular order found between the molecules in the
systems, i.e. maximum amount of intermolecular interactions,
resulted in physically more stable systems regardless of the
Tg.
26,39
Several studies on thermal changes in chemical bonding of
glass-formers around Tg, focusing on diﬀerent functional
groups, were performed previously with IR spectroscopy.41,42
However, these measurements did not speciﬁcally aim to
resolve any changes in the corresponding vibrational modes
around Tβ ≈ 0.67 Tg and only report data at higher
temperatures. Careful low-temperature FTIR analysis of
sorbitol however clearly shows a signiﬁcant change in the
−OH stretch mode observed around 3300−3500 cm−1
(approximately 100 THz) in both Tg and 0.67 Tg thermal
regions and conﬁrms the presence of changes in the
intermolecular hydrogen bonding at these temperatures.43
We attempted to perform a similar FTIR analysis on
paracetamol, where the signature of Tβ is the strongest. There is
some quantitative change in the spectra with temperature, in
particular around Tg, but in paracetamol the −OH stretch
region is strongly broadened and overlaps with the −CH
stretch region and others (data not shown) and hence the
process cannot be resolved. This is a common scenario for
many larger molecular systems that makes it impossible to
conclusively resolve the underlying changes in intermolecular
hydrogen bonding based on FTIR (or Raman at mid infrared
frequencies) data.
While the samples studied in this work form intermolecular
hydrogen bonds, there is also a signiﬁcant proportion of weak
van der Waals dipolar intermolecular interaction present. Given
the clear observation of Tβ by THz-TDS in all cases it is
however very likely that Tβ is originating from the disorder in
the samples rather than a speciﬁc type of intermolecular
bonding. This question will need to be further addressed in
future studies.
Role of Tβ for the Stability of Amorphous Drugs. The
results presented in this paper point toward two very important
conclusions:
First, the terahertz absorption increase between Tβ and Tg
correlates with the stability of amorphous drug molecules. We
show that the fast (GHz-THz) molecular processes are
governing the stability and crystallization of the amorphous
materials below Tg. An analogous conclusion has been
previously reached in terms of protein stability in glassy
matrices by Cicerone et al. as measured by neutron scattering.18
THz-TDS could therefore oﬀer a convenient analytical method
to assess amorphous drug or lyophilized protein stability
without the necessity to perform midterm or long-term storage
stability experiments. The robustness of terahertz spectroscopy
is based on the ability to directly quantify the intermolecular
mobility in amorphous organic solids.
Second, the presence of increased mobility above Tβ means
that crystallization at these temperatures is facilitated, and
storing amorphous materials at Tg − 20 K or Tg − 50 K may
still not provide a stable environment for the glass, as shown for
the case of naproxen. It should however be highlighted that the
molecular mobility is facilitating rather than actively driving the
structural changes and is not the only factor involved in the
crystallization of amorphous materials.44
Some links between the secondary relaxations and nucleation
were reported in the earlier work of Oguni et al.12,13 The
authors previously reported a possibility to resolve a secondary
glass transition in molecular glasses at temperatures below
Tg.
45,46
In order to elaborate on this, we have performed a
calorimetry study of all four drug samples, covering temper-
atures well below 0.67 Tg. We have found no change in the heat
ﬂow at temperatures below Tg. It is important to note in this
context that Fujimori and Oguni used a very sensitive adiabatic
calorimetry technique which is more sensitive than the
technique used in our experiments.47 The inability of standard
DSC measurements to resolve Tβ makes it impossible to use for
routine sub-Tg analysis. While the sensitive adiabatic calorim-
etry measurements show clearly that there is a weak
thermodynamic signature of a secondary glass transition in
molecular glasses, the strong observation of Tβ by THz-TDS
hints toward a predominately kinetic nature of Tβ, associated
with a change in picosecond molecular dynamics. Given that Tβ
is much lower than Tg in the samples studied, it is highly
unlikely to be related to the α-relaxation. This suggests that
using the extrapolated primary relaxation time as a parameter to
describe the molecular dynamics at temperatures signiﬁcantly
below Tg, regardless of whether this is based on dielectric or
thermodynamic data, is unlikely to yield in a good stability
parameter.
■ CONCLUSION AND OUTLOOKS
This study showed that the terahertz molecular dynamics is
strongly related to the molecular mobility governing the
stability of amorphous drugs. While molecular relaxations are
often extracted by dielectric spectroscopy or DSC and used to
predict the stability of the amorphous drugs, concerns have
been raised about the robustness of these methods.3,14 DSC is
useful mainly for measurements of molecular mobility around
and above Tg but cannot be easily used to measure molecular
mobility at lower temperatures. Measurements by dielectric
spectroscopy are very useful for measuring the local mobility in
terms of JG-β relaxation, except for cases where this relaxation
is submerged in the α-relaxation. In contrast, terahertz
spectroscopy does not suﬀer from this limitation as it measures
fast motions and only indirectly resolves the eﬀect of the JG-β
relaxation, which may in principle be observed even when no
clear JG-β peak is present (such as in the case of indomethacin
in this study). This emphasizes the robustness of terahertz/
picosecond intermolecular dynamics analysis. Several diﬀerent
techniques, such as light scattering, neutron scattering, or
optical Kerr eﬀect can probe these dynamics as well, yet little
focus has been given thus far to systematically examine any
evidence of a change in molecular dynamics around 0.67 Tg. It
would be however very valuable to do so in the future.
It is important to keep in mind that the terahertz analysis
alone may not provide complete insight into all factors
inﬂuencing the stability of amorphous materials. It however
oﬀers a very promising and easily accessible complementary
analytical technique to more commonly used thermal and
spectroscopic methods, oﬀering an insight into the fast
molecular dynamics that rule the physical stability and
crystallization of amorphous materials.
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(3) Laitinen, R.; Löbmann, K.; Strachan, C. J.; Grohganz, H.; Rades,
T. Emerging trends in the stabilization of amorphous drugs. Int. J.
Pharm. 2013, 453, 65−79.
(4) Yu, L. Amorphous pharmaceutical solids: preparation, character-
ization and stabilization. Adv. Drug Delivery Rev. 2001, 48, 27−42.
(5) Marsac, P.; Shamblin, S.; Taylor, L. Theoretical and Practical
Approaches for Prediction of Drug-Polymer Miscibility and Solubility.
Pharm. Res. 2006, 23, 2417−2426.
(6) Zhou, D.; Grant, D.; Zhang, G.; Law, D.; Schmitt, E. Physical
stability of amorphous pharmaceuticals: importance of configurational
thermodynamic quantities and molecular mobility. J. Pharm. Sci. 2002,
96, 71−83.
(7) Andronis, V.; Zografi, G. Molecular Mobility of Supercooled
Amorphous Indomethacin, Determined by Dynamic Mechanical
Analysis. Pharm. Res. 1997, 14, 410−414.
(8) DiMartino, P.; Palmieri, G.; Martelli, S. Molecular mobility of the
paracetamol amorphous form. Chem. Pharm. Bull. 2000, 8, 1105−
1108.
(9) Kaushal, A. M.; Bansal, A. K. Thermodynamic behavior of glassy
state of structurally related compounds. Eur. J. Pharm. Biopharm. 2008,
69, 1067−1076.
(10) Ambike, A. A.; Mahadik, K. R.; Paradkar, A. Physico-Chemical
Characterization and Stability Study of Glassy Simvastatin. Drug Dev.
Ind. Pharm. 2005, 31, 895−899.
(11) Fukuoka, E.; Makita, M.; Yamamura, S. Glassy State of
Pharmaceuticals. III. Thermal Properties and Stability of Glassy
Pharmaceuticals and Their Binary Glass Systems. Chem. Pharm. Bull.
1989, 37, 1047−1050.
(12) Okamoto, N.; Oguni, M. Discovery of crystal nucleation
proceeding much below the glass transition temperature in a
supercooled liquid. Solid State Commun. 1996, 99, 53−56.
(13) Hikima, T.; Hanaya, M.; Oguni, M. Microscopic observation of
a peculiar crystallization in the glass transition region and beta-process
as potentially controlling the growth rate in triphenylethylene. J. Mol.
Struct. 1999, 479, 245−250.
(14) Bhattacharya, S.; Suryanarayanan, R. Local Mobility in
Amorphous Pharmaceuticals − Characterization and Implications on
Stability. J. Pharm. Sci. 2009, 98, 2935−2953.
(15) Grzybowska, K.; Paluch, M.; Grzybowski, A.; Wojnarowska, Z.;
Hawelek, L.; Kolodziejczyk, K.; Ngai, K. L. Molecular dynamics and
physical stability of amorphous anti-inflammatory drug: celecoxib. J.
Phys. Chem. B 2010, 114, 12792−12801.
(16) Sokolov, A.; Kisliuk, A.; Novikov, V.; Ngai, K. Observation of
constant loss in fast relaxation spectra of polymers. Phys. Rev. B 2001,
63, 172204.
(17) Ngai, K. L. Why the fast relaxation in the picosecond to
nanosecond time range can sense the glass transition. Philos. Mag.
2004, 84, 1341−1353.
(18) Cicerone, M. T.; Douglas, J. F. β-Relaxation governs protein
stability in sugar-glass matrices. Soft Matter 2012, 8, 2983−2991.
(19) Sibik, J.; Elliott, S. R.; Zeitler, J. A. Thermal Decoupling of
Molecular-Relaxation Processes from the Vibrational Density of States
at Terahertz Frequencies in Supercooled Hydrogen-Bonded Liquids. J.
Phys. Chem. Lett. 2014, 5, 1968−1972.
(20) Parrott, E. P. J.; Zeitler, J. A.; Frisčǐc,́ T.; Pepper, M.; Jones, W.;
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